iRhythm Technologies, Inc. (NASDAQ:IRTC) Files An 8-K Results of Operations and Financial Condition

Item 2.02.Results of Operations and Financial Condition.

On December 5, 2016, iRhythm Technologies, Inc. issued a press
release regarding its financial results for the quarter ended
September 30, 2016. A copy of the press release is furnished as
Exhibit 99.1 to this Form 8-K.

This information is intended to be furnished under Item 2.02 of
Form 8-K and shall not be deemed filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such a
filing.

Item 9.01.Financial Statements and Exhibits.

About iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its algorithms analyze the amounts of captured heart beat data and a concise report is provided to the patient’s physician. Its ZIO Report produces a higher diagnostic yield and to change patient management.

iRhythm Technologies, Inc. (NASDAQ:IRTC) Recent Trading Information

iRhythm Technologies, Inc. (NASDAQ:IRTC) closed its last trading session up +0.17 at 29.15 with 198,368 shares trading hands.